Ditchcarbon
  • Customers
  1. Organizations
  2. CHINA NATIONAL PHARMACEUTICAL GROUP
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 5 days ago

CHINA NATIONAL PHARMACEUTICAL GROUP

Company website

China National Pharmaceutical Group, commonly known as Sinopharm, is a leading player in the pharmaceutical and healthcare industry, headquartered in Beijing, China. Established in 1998, Sinopharm has rapidly expanded its operations across various regions, including Asia, Europe, and Africa, solidifying its position as a global healthcare provider. The company focuses on the research, development, manufacturing, and distribution of pharmaceuticals, medical devices, and healthcare services. Sinopharm is particularly renowned for its extensive portfolio of vaccines and innovative biopharmaceuticals, which are distinguished by their quality and efficacy. With a strong market presence, Sinopharm has achieved significant milestones, including being listed among the Fortune Global 500. Its commitment to advancing healthcare solutions continues to drive its reputation as a trusted leader in the pharmaceutical sector.

DitchCarbon Score

How does CHINA NATIONAL PHARMACEUTICAL GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

CHINA NATIONAL PHARMACEUTICAL GROUP's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

CHINA NATIONAL PHARMACEUTICAL GROUP's reported carbon emissions

In 2023, China National Pharmaceutical Group (Sinopharm) reported total carbon emissions of approximately 26,341,5270 kg CO2e, comprising about 54,715,050 kg CO2e from Scope 1 and about 208,700,220 kg CO2e from Scope 2 emissions. This marks a slight increase from 2022, where total emissions were approximately 25,310,5280 kg CO2e, with Scope 1 emissions at about 52,434,340 kg CO2e and Scope 2 emissions at about 200,670,940 kg CO2e. Sinopharm has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. The company has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, suggesting a need for enhanced climate commitments in line with industry standards. Overall, while Sinopharm has made strides in emissions reporting, the absence of reduction targets and Scope 3 data highlights opportunities for further engagement in climate action and sustainability practices.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20182019202020222023
Scope 1
30,741,540
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
88,611,470
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CHINA NATIONAL PHARMACEUTICAL GROUP's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CHINA NATIONAL PHARMACEUTICAL GROUP is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CHINA NATIONAL PHARMACEUTICAL GROUP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Panasonic

JP
•
Electrical machinery and apparatus n.e.c. (31)
Updated about 8 hours ago

AstraZeneca AB

SE
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Shanghai Pharmaceuticals

CN
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

C.Q. Pharmaceutical Holding Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Huadong Medicine Co., Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy